Muros, M A <br/><br/>
Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues.  [electronic resource] 

 -  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico  Jan 2009 
 - 48-53 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1699-048X 
<br/><br/><label>Standard No.: </label>10.1007/s12094-009-0310-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuroendocrine Tumors--mortality<br/>Octreotide--analogs & derivatives<br/>Organometallic Compounds--therapeutic use<br/>Quality of Life<br/>Somatostatin--analogs & derivatives<br/>Treatment Outcome